Elsevier

Genomics

Volume 75, Issues 1–3, July 2001, Pages 17-25
Genomics

Regular Article
Transcript Map of the 8p23 Putative Tumor Suppressor Region

https://doi.org/10.1006/geno.2001.6587Get rights and content

Abstract

Cancers of the head and neck, prostate, liver, and bladder exhibit minimal regions of deletion within chromosomal band 8p23 that either overlap or map very close to one another. We previously refined a minimal region of deletion in squamous cell carcinomas to a 112-kb interval within 8p23. There seems to be only a single gene within this region that is expressed in normal upper aerodigestive tract epithelium. This candidate for the squamous cancer suppressor, CUB and sushi multiple domains-1 (CSMD1), extends into the minimal regions of deletions defined for the other types of cancer with 8p23 deletions. RT-PCR and EST data indicate that CSMD1 is also expressed in those organs,making this gene a candidate for a suppressor of multiple types of cancer. Both the sequence of the gene and the organization of the protein are highly conserved in the mouse.

References (42)

  • A.M. Blom et al.

    The C4b-binding protein-protein S interaction is hydrophobic in nature. Biochim

    Biophys. Acta

    (1998)
  • K. Shimizu-Nishikawa et al.

    Cloning and characterization of seizure-related gene, SEZ-6

    Biochem. Biophys. Res. Commun.

    (1995)
  • R. Herbst et al.

    SEZ-6: promoter selectivity, genomic structure and localized expression in the brain

    Mol. Brain Res.

    (1997)
  • C. Burge et al.

    Prediction of complete gene structures in human genomic DNA

    J. Mol. Biol.

    (1997)
  • J.B. Sunwoo et al.

    Evidence for multiple tumor suppressor genes on chromosome arm 8p in supraglottic laryngeal cancer

    Genes Chromosom. Cancer

    (1996)
  • C.L. Wu

    Deletion mapping defines three discrete areas of allelic imbalance on chromosome arm 8p in oral and oropharyngeal squamous cell carcinomas

    Genes Chromosom. Cancer

    (1997)
  • J.B. Sunwoo et al.

    Localization of a putative tumor suppressor gene in the sub-telomeric region of chro-mosome 8p

    Oncogene

    (1999)
  • C.S. Ishwad

    Frequent allelic loss and homozygous deletion in chromosome band 8p23 in oral cancer

    Int. J. Cancer

    (1999)
  • S.B. Scholnick

    Chromosome 8 allelic loss and the outcome of patients with squamous cell carcinoma of the supraglottic larynx

    J. Natl. Cancer. Inst.

    (1996)
  • J.G. Washburn et al.

    8pter-p23 deletion is associated with racial differences in prostate cancer outcome

    Clin. Cancer Res.

    (2001)
  • Cited by (67)

    • CSMD1 suppresses cancer progression by inhibiting proliferation, epithelial-mesenchymal transition, chemotherapy-resistance and inducing immunosuppression in esophageal squamous cell carcinoma

      2022, Experimental Cell Research
      Citation Excerpt :

      Secondly, at the DNA level, the loss of CSMD1 in a large proportion of head and neck squamous cell carcinoma (HNSCC), breast cancers and lung squamous cell carcinoma through an array-based comparative genomic hybridization study [30]. Some studies performed quantitative real time PCR (qPCR) and western blotting assays to reveal the loss of CSMD1 expression in lung SCCs, HNSCCs, liver, colorectal and prostate cancer [8,13,14]. Thirdly, microRNA-10b targets CSMD1 to promote gastric cancer progression [31].

    • Novel potential inhibitors of complement system and their roles in complement regulation and beyond

      2018, Molecular Immunology
      Citation Excerpt :

      Such interactions have been reported in the literature for known regulators of neuronal migration and synapses formation that share homologous structures (Gaboriaud et al., 2011; Ng et al., 2009; Brown and Bridgman, 2009; Chen et al., 2008). Allelic loss, mutations, and methylations of the CSMD gene family chromosomal locus has been reported in a number of malignancies (head and neck, breast, prostate, colorectal, liver, lung, skin, squamous cell carcinoma) suggesting a role of the CSMD family members as putative tumor suppressors (Sun et al., 2001; Liu et al., 2012; Zhang and Song, 2014; Ma et al., 2009; Scholnick and Richter, 2003; Toomes et al., 2003; Midorikawa et al., 2009). In addition, a decrease in CSMD1 expression has been linked to poor prognosis and shorter survival of cancer patients (Escudero-Esparza et al., 2016; Toomes et al., 2003; Richter et al., 2005; Scholnick et al., 1996).

    • CSMD1

      2018, The Complement FactsBook: Second Edition
    View all citing articles on Scopus
    *

    To whom correspondence and reprint requests should be addressed. Fax: 314-367-7346. E-mail: [email protected].

    View full text